Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381716466> ?p ?o ?g. }
- W4381716466 endingPage "999" @default.
- W4381716466 startingPage "987" @default.
- W4381716466 abstract "Poly(ADP-ribose) polymerase 2 (PARP2) alongside PARP1 are responsible for the bulk of cellular PARP activity, and they were first described as DNA repair factors. However, research in past decades implicated PARPs in biological functions as diverse as the regulation of cellular energetics, lipid homeostasis, cell death, and inflammation. PARP activation was described in Th2-mediated inflammatory processes, but studies focused on the role of PARP1, while we have little information on PARP2 in inflammatory regulation. In this study, we assessed the role of PARP2 in a Th17-mediated inflammatory skin condition, psoriasis. We found that PARP2 mRNA expression is increased in human psoriatic lesions. Therefore, we studied the functional consequence of decreased PARP2 expression in murine and cellular human models of psoriasis. We observed that the deletion of PARP2 attenuated the imiquimod-induced psoriasis-like dermatitis in mice. Silencing of PARP2 in human keratinocytes prevented their hyperproliferation, maintained their terminal differentiation, and reduced their production of inflammatory mediators after treatment with psoriasis-mimicking cytokines IL17A and TNFα. Underlying these observations, we found that aromatase was induced in the epidermis of PARP2 knock-out mice and in PARP2-deficient human keratinocytes, and the resulting higher estradiol production suppressed NF-κB activation, and hence, inflammation in keratinocytes. Steroidogenic alterations have previously been described in psoriasis, and we extend these observations by showing that aromatase expression is reduced in psoriatic lesions. Collectively, our data identify PARP2 as a modulator of estrogen biosynthesis by epidermal keratinocytes that may be relevant in Th17 type inflammation. KEY MESSAGES : PARP2 mRNA expression is increased in lesional skin of psoriasis patients. PARP2 deletion in mice attenuated IMQ-induced psoriasis-like dermatitis. NF-κB activation is suppressed in PARP2-deficient human keratinocytes. Higher estradiol in PARP2-deficient keratinocytes conveys anti-inflammatory effect." @default.
- W4381716466 created "2023-06-24" @default.
- W4381716466 creator A5004722620 @default.
- W4381716466 creator A5010130460 @default.
- W4381716466 creator A5014698046 @default.
- W4381716466 creator A5019579875 @default.
- W4381716466 creator A5032666916 @default.
- W4381716466 creator A5037698851 @default.
- W4381716466 creator A5045373730 @default.
- W4381716466 creator A5059452573 @default.
- W4381716466 creator A5075953397 @default.
- W4381716466 creator A5077174799 @default.
- W4381716466 creator A5078451219 @default.
- W4381716466 creator A5082542719 @default.
- W4381716466 date "2023-06-23" @default.
- W4381716466 modified "2023-10-15" @default.
- W4381716466 title "PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes" @default.
- W4381716466 cites W1502422406 @default.
- W4381716466 cites W1502768817 @default.
- W4381716466 cites W1703103639 @default.
- W4381716466 cites W1969696561 @default.
- W4381716466 cites W1970910000 @default.
- W4381716466 cites W1975445106 @default.
- W4381716466 cites W1976591271 @default.
- W4381716466 cites W1982421644 @default.
- W4381716466 cites W1983566327 @default.
- W4381716466 cites W1991217781 @default.
- W4381716466 cites W1993057625 @default.
- W4381716466 cites W2007462046 @default.
- W4381716466 cites W2016897508 @default.
- W4381716466 cites W2026161220 @default.
- W4381716466 cites W2026791577 @default.
- W4381716466 cites W2035586696 @default.
- W4381716466 cites W2037586865 @default.
- W4381716466 cites W2037746176 @default.
- W4381716466 cites W2042859356 @default.
- W4381716466 cites W2059032249 @default.
- W4381716466 cites W2063377993 @default.
- W4381716466 cites W2094792719 @default.
- W4381716466 cites W2103018315 @default.
- W4381716466 cites W2106390123 @default.
- W4381716466 cites W2106686862 @default.
- W4381716466 cites W2107432039 @default.
- W4381716466 cites W2121618450 @default.
- W4381716466 cites W2131556221 @default.
- W4381716466 cites W2147119127 @default.
- W4381716466 cites W2152559121 @default.
- W4381716466 cites W2159203244 @default.
- W4381716466 cites W2263619077 @default.
- W4381716466 cites W2265965451 @default.
- W4381716466 cites W2340085315 @default.
- W4381716466 cites W2340696274 @default.
- W4381716466 cites W2514167322 @default.
- W4381716466 cites W2591591213 @default.
- W4381716466 cites W2789092379 @default.
- W4381716466 cites W2797087287 @default.
- W4381716466 cites W2887024783 @default.
- W4381716466 cites W2887026298 @default.
- W4381716466 cites W2911246983 @default.
- W4381716466 cites W2955535371 @default.
- W4381716466 cites W2989928885 @default.
- W4381716466 cites W3004779294 @default.
- W4381716466 cites W3005531462 @default.
- W4381716466 cites W3039695461 @default.
- W4381716466 cites W3193660656 @default.
- W4381716466 cites W4210402818 @default.
- W4381716466 cites W4281479908 @default.
- W4381716466 doi "https://doi.org/10.1007/s00109-023-02338-z" @default.
- W4381716466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37351597" @default.
- W4381716466 hasPublicationYear "2023" @default.
- W4381716466 type Work @default.
- W4381716466 citedByCount "0" @default.
- W4381716466 crossrefType "journal-article" @default.
- W4381716466 hasAuthorship W4381716466A5004722620 @default.
- W4381716466 hasAuthorship W4381716466A5010130460 @default.
- W4381716466 hasAuthorship W4381716466A5014698046 @default.
- W4381716466 hasAuthorship W4381716466A5019579875 @default.
- W4381716466 hasAuthorship W4381716466A5032666916 @default.
- W4381716466 hasAuthorship W4381716466A5037698851 @default.
- W4381716466 hasAuthorship W4381716466A5045373730 @default.
- W4381716466 hasAuthorship W4381716466A5059452573 @default.
- W4381716466 hasAuthorship W4381716466A5075953397 @default.
- W4381716466 hasAuthorship W4381716466A5077174799 @default.
- W4381716466 hasAuthorship W4381716466A5078451219 @default.
- W4381716466 hasAuthorship W4381716466A5082542719 @default.
- W4381716466 hasBestOaLocation W43817164661 @default.
- W4381716466 hasConcept C118995209 @default.
- W4381716466 hasConcept C202751555 @default.
- W4381716466 hasConcept C203014093 @default.
- W4381716466 hasConcept C20639190 @default.
- W4381716466 hasConcept C2776914184 @default.
- W4381716466 hasConcept C2777074287 @default.
- W4381716466 hasConcept C2780564577 @default.
- W4381716466 hasConcept C502942594 @default.
- W4381716466 hasConcept C54355233 @default.
- W4381716466 hasConcept C55493867 @default.
- W4381716466 hasConcept C81885089 @default.
- W4381716466 hasConcept C86803240 @default.